Cargando…

Introduction to “Immunotherapies for Multiple Myeloma”

Detalles Bibliográficos
Autores principales: Offidani, Massimo, Petrucci, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696150/
https://www.ncbi.nlm.nih.gov/pubmed/33212754
http://dx.doi.org/10.3390/ph13110396
_version_ 1783615343680290816
author Offidani, Massimo
Petrucci, Maria Teresa
author_facet Offidani, Massimo
Petrucci, Maria Teresa
author_sort Offidani, Massimo
collection PubMed
description
format Online
Article
Text
id pubmed-7696150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76961502020-11-29 Introduction to “Immunotherapies for Multiple Myeloma” Offidani, Massimo Petrucci, Maria Teresa Pharmaceuticals (Basel) Editorial MDPI 2020-11-17 /pmc/articles/PMC7696150/ /pubmed/33212754 http://dx.doi.org/10.3390/ph13110396 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Offidani, Massimo
Petrucci, Maria Teresa
Introduction to “Immunotherapies for Multiple Myeloma”
title Introduction to “Immunotherapies for Multiple Myeloma”
title_full Introduction to “Immunotherapies for Multiple Myeloma”
title_fullStr Introduction to “Immunotherapies for Multiple Myeloma”
title_full_unstemmed Introduction to “Immunotherapies for Multiple Myeloma”
title_short Introduction to “Immunotherapies for Multiple Myeloma”
title_sort introduction to “immunotherapies for multiple myeloma”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696150/
https://www.ncbi.nlm.nih.gov/pubmed/33212754
http://dx.doi.org/10.3390/ph13110396
work_keys_str_mv AT offidanimassimo introductiontoimmunotherapiesformultiplemyeloma
AT petruccimariateresa introductiontoimmunotherapiesformultiplemyeloma